Clearside Biomedical, Inc. CLSDQ
0.25 USD 0.00 (+0.00%)
At closeJul 22, 2026, 4:00 PM EDT
0.249 Day range 0.31
0.01 52-week range 8.70
- YTD
- -64.68%
- 1 year
- -98.02%
- Market cap
- 1.30M
- EPS (ttm)
- -2.25
- P/E ratio
- -0.11
- YTD return
- -64.68%
- 1-year return
- -98.02%
- Volume
- 106
- Avg volume
- 4.16K
- Open
- 0.31
- Previous close
- 0.249
- Day's range
- 0.249 – 0.31
- 52-week range
- 0.01 – 8.70
No chart data for this range yet.
Financials — quick view
CLSDQ Revenue — quarterly 0
CLSDQ Net income — quarterly -5.97M
CLSDQ EPS — quarterly -1.14
News
Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process 
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates 
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Recommendation of “Hold” from Brokerages 
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress 
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates 
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada 
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline 
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting 
Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know 
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
Your note
Sign in to keep a note on CLSDQ — it syncs with the Stock Master app.